Trial Profile
Evaluation of Palonosetron and Palonosetron/Aprepitant in Post Operative Nausea and Vomiting Incidence in Oncological Patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Apr 2017
Price :
$35
*
At a glance
- Drugs Aprepitant (Primary) ; Dexamethasone; Palonosetron
- Indications Postoperative nausea and vomiting
- Focus Therapeutic Use
- 05 May 2015 New trial record